Get App Open
In App
Lending
Lending
Open App
Success
Alert
Please select a Day.
Info

FDC Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

63/100
411.00
-2.95 (-0.71%)

As on 21 Nov, 2025 | 03:49

Open Trading A/c
Day Range
408.05
416.10
L H
52 Week Range
366.25
527.80
L H
Volume
54,074
*
i

* BSE Market Depth (21 Nov 2025)

BUY SELL
QTY PRICE PRICE QTY
122 409.75 418.60 6
122 409.70 419.40 16
8 409.55 420.00 1
8 408.85 422.00 5
1 408.05 424.65 10
0 Total Total 0
Bid / Ask
0.00 / 0.00
63/100
409.75
-4.90 (-1.18%)

As on 21 Nov, 2025 | 04:01

Open Trading A/c
Day Range
408.05
415.20
L H
52 Week Range
358.95
530.00
L H
Volume
4,671
*
i

* BSE Market Depth (21 Nov 2025)

BUY SELL
QTY PRICE PRICE QTY
122 409.75 418.60 6
122 409.70 419.40 16
8 409.55 420.00 1
8 408.85 422.00 5
1 408.05 424.65 10
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
59% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, Average Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 413.95
          Previous Close 413.95
          Volume 54,074.00
          Value (Lacs) 222.24
            VWAP 411.05
          Beta
          Mkt Cap (Rs. Cr.) 6,691
          High 416.10
          Low 408.05
          UC Limit 496.70
          LC Limit 331.20
          52 Week High 527.80
          52 Week Low 366.25
          Face Value 1.00
          All Time High 658.85
          All Time Low 8.10
          20D Avg Volume 193,559
          20D Avg Delivery(%) 48.62
          Book Value Per Share 140.11
          Dividend Yield 1.22
          TTM EPS See historical trend 13.85 (-28.77% YoY)
          TTM PE See historical trend 29.68 (High PE)
          P/B See historical trend 2.94 (Average P/B)
          Sector PE 39.94

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          63/100
          Superior Financial Strength, Average Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 22.13% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 69.66% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          10 out of 17 years FDC has given negative returns in November.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          November 21.01% (2013) 7.97% -14.31% (2011) -7.20% -0.95%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying FDC

          What's your call on FDC today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          12 Sep, 2024

          Graviton Research Capital Llp

          Qty 1075388 Price 631.46 % Traded 0.68
          12 Sep, 2024

          Graviton Research Capital Llp

          Qty 1075388 Price 631.92 % Traded 0.68

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          FDC 411.00 -0.71 6,691.49 29.68 2.93 11.69 -15.35 266 2,108 0.00
          Sun Pharma 1,779.70 0.13 427,009.64 40.87 5.91 15.13 -0.02 10,980 52,578 0.03
          Divis Labs 6,373.00 -1.38 169,183.13 68.08 11.30 14.63 6.62 2,191 9,360 0.00
          Torrent Pharma 3,686.50 -0.94 124,767.91 58.30 16.63 25.17 18.84 1,911 11,516 0.40
          Cipla 1,511.80 -1.14 122,118.85 22.44 3.91 16.90 3.16 5,291 27,547 0.00

          About the Company

          FDC Ltd made a modest beginning with marketing of vitamins and a range of prescription formulations.The company subsequently set up their formulations manufacturing facility and also pioneered the manufacture of specialized ophthalmic formulations in India.FDC initiated the concept of Oral Rehydration Salts (ORS) and today their pioneer brand Electral stands apart with a special identity- an impressive achievement in a fiercely competitive market. The company product spectrum includes the following:Therapeutic Products-Anti Fungals/Dermatological,Anti-Anaemic,Anti-Diabetic,Anti-Diarrhoeals/ Intestinals/ ORS Anti-Haemorrhagics,Anti-Oxidants,Anti-Spasmodics,Antibiotics/Antibacterials,Antiemetic/ Antinauseant etc.Food-Vitamins And Nutraceuticals.Bulk Drug-Albuterol Sulfate,Betaxolol Hydrochloride,Brimonidine Tartrate,Bromhexine Hydrochloride,Cinnarizine etc,Active Pharmaceutical Ingredients (API) Under Development-Azelastine HCl,Brinzolamide,Duloxetine HCl,Gemifloxacine Mesylate,Latanoprost,Levo-Betaxolol HCl,Olopatadine HCl,Pregabalin,Rupatadine Fumarate,Voriconazole,etc
          {"success":1,"data":{"address":{"address1":"B-8, MIDC Industrial Estate,","address2":",Chhatrapati Sambhaji Nagar,","city":"Aurangabad District","state":"Maharashtra","pincode":"431136","telephone1":"0240-2554407","telephone2":"0240-2554299","fax1":"0240-2554299","fax2":"","email":"investors@fdcindia.com","web":"http:\/\/www.fdcindia.com"},"management":[{"name":"Uday Kumar Gurkar","designation":"Chairman & Ind.Director"},{"name":"Mohan A Chandavarkar","designation":"Managing Director"},{"name":"Nandan M Chandavarkar","designation":"Joint Managing Director"},{"name":"Ameya A Chandavarkar","designation":"Executive Director & CEO"},{"name":"Ashok A Chandavarkar","designation":"Executive Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"Yes"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"531599","nseId":"FDC","series":"EQ","isinid":"INE258B01022"}}}
          • Registered Office

            • Address

              B-8, MIDC Industrial Estate,,,Chhatrapati Sambhaji Nagar,

            • City

              Aurangabad District

            • State

              Maharashtra

            • Pin Code

              431136

            • Tel. No.

              0240-2554407

            • Fax No.

              0240-2554299

            • Email

              investors@fdcindia.com

            • Internet

              http://www.fdcindia.com

          • Registrars

          • Management

            • Uday Kumar Gurkar

              Chairman & Ind.Director

            • Mohan A Chandavarkar

              Managing Director

            • Nandan M Chandavarkar

              Joint Managing Director

            • Ameya A Chandavarkar

              Executive Director & CEO

            • Ashok A Chandavarkar

              Executive Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              Yes

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              531599

            • NSE:

              FDC

            • Series

              EQ

            • ISIN

              INE258B01022

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347